Cargando…
P04-18. Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: results from the NeutNet working group
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767947/ http://dx.doi.org/10.1186/1742-4690-6-S3-P46 |
| _version_ | 1782173415247970304 |
|---|---|
| author | Scarlatti, G Alcami, J Bongertz, V Fenyö, E Heath, A Heyndrickx, L Holmes, H Jansson, M Lopalco, L Malnati, M Montefiori, D Moog, C Morris, L Osmanov, S Polonis, V Ramaswamy, M Sattentau, Q Schuitemaker, H Wrin, T |
| author_facet | Scarlatti, G Alcami, J Bongertz, V Fenyö, E Heath, A Heyndrickx, L Holmes, H Jansson, M Lopalco, L Malnati, M Montefiori, D Moog, C Morris, L Osmanov, S Polonis, V Ramaswamy, M Sattentau, Q Schuitemaker, H Wrin, T |
| author_sort | Scarlatti, G |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2767947 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2009 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-27679472009-10-28 P04-18. Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: results from the NeutNet working group Scarlatti, G Alcami, J Bongertz, V Fenyö, E Heath, A Heyndrickx, L Holmes, H Jansson, M Lopalco, L Malnati, M Montefiori, D Moog, C Morris, L Osmanov, S Polonis, V Ramaswamy, M Sattentau, Q Schuitemaker, H Wrin, T Retrovirology Poster Presentation BioMed Central 2009-10-22 /pmc/articles/PMC2767947/ http://dx.doi.org/10.1186/1742-4690-6-S3-P46 Text en Copyright © 2009 Scarlatti et al; licensee BioMed Central Ltd. |
| spellingShingle | Poster Presentation Scarlatti, G Alcami, J Bongertz, V Fenyö, E Heath, A Heyndrickx, L Holmes, H Jansson, M Lopalco, L Malnati, M Montefiori, D Moog, C Morris, L Osmanov, S Polonis, V Ramaswamy, M Sattentau, Q Schuitemaker, H Wrin, T P04-18. Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: results from the NeutNet working group |
| title | P04-18. Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: results from the NeutNet working group |
| title_full | P04-18. Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: results from the NeutNet working group |
| title_fullStr | P04-18. Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: results from the NeutNet working group |
| title_full_unstemmed | P04-18. Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: results from the NeutNet working group |
| title_short | P04-18. Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: results from the NeutNet working group |
| title_sort | p04-18. comparison of hiv neutralization assays for use in vaccine research and clinical trials, phase ii: results from the neutnet working group |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767947/ http://dx.doi.org/10.1186/1742-4690-6-S3-P46 |
| work_keys_str_mv | AT scarlattig p0418comparisonofhivneutralizationassaysforuseinvaccineresearchandclinicaltrialsphaseiiresultsfromtheneutnetworkinggroup AT alcamij p0418comparisonofhivneutralizationassaysforuseinvaccineresearchandclinicaltrialsphaseiiresultsfromtheneutnetworkinggroup AT bongertzv p0418comparisonofhivneutralizationassaysforuseinvaccineresearchandclinicaltrialsphaseiiresultsfromtheneutnetworkinggroup AT fenyoe p0418comparisonofhivneutralizationassaysforuseinvaccineresearchandclinicaltrialsphaseiiresultsfromtheneutnetworkinggroup AT heatha p0418comparisonofhivneutralizationassaysforuseinvaccineresearchandclinicaltrialsphaseiiresultsfromtheneutnetworkinggroup AT heyndrickxl p0418comparisonofhivneutralizationassaysforuseinvaccineresearchandclinicaltrialsphaseiiresultsfromtheneutnetworkinggroup AT holmesh p0418comparisonofhivneutralizationassaysforuseinvaccineresearchandclinicaltrialsphaseiiresultsfromtheneutnetworkinggroup AT janssonm p0418comparisonofhivneutralizationassaysforuseinvaccineresearchandclinicaltrialsphaseiiresultsfromtheneutnetworkinggroup AT lopalcol p0418comparisonofhivneutralizationassaysforuseinvaccineresearchandclinicaltrialsphaseiiresultsfromtheneutnetworkinggroup AT malnatim p0418comparisonofhivneutralizationassaysforuseinvaccineresearchandclinicaltrialsphaseiiresultsfromtheneutnetworkinggroup AT montefiorid p0418comparisonofhivneutralizationassaysforuseinvaccineresearchandclinicaltrialsphaseiiresultsfromtheneutnetworkinggroup AT moogc p0418comparisonofhivneutralizationassaysforuseinvaccineresearchandclinicaltrialsphaseiiresultsfromtheneutnetworkinggroup AT morrisl p0418comparisonofhivneutralizationassaysforuseinvaccineresearchandclinicaltrialsphaseiiresultsfromtheneutnetworkinggroup AT osmanovs p0418comparisonofhivneutralizationassaysforuseinvaccineresearchandclinicaltrialsphaseiiresultsfromtheneutnetworkinggroup AT polonisv p0418comparisonofhivneutralizationassaysforuseinvaccineresearchandclinicaltrialsphaseiiresultsfromtheneutnetworkinggroup AT ramaswamym p0418comparisonofhivneutralizationassaysforuseinvaccineresearchandclinicaltrialsphaseiiresultsfromtheneutnetworkinggroup AT sattentauq p0418comparisonofhivneutralizationassaysforuseinvaccineresearchandclinicaltrialsphaseiiresultsfromtheneutnetworkinggroup AT schuitemakerh p0418comparisonofhivneutralizationassaysforuseinvaccineresearchandclinicaltrialsphaseiiresultsfromtheneutnetworkinggroup AT wrint p0418comparisonofhivneutralizationassaysforuseinvaccineresearchandclinicaltrialsphaseiiresultsfromtheneutnetworkinggroup |